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Export ofmRNA from the cell nucleus to the cytoplasm is essential for protein synthesis, a process vital to all living eukaryotic cells.mRNA
export is highly conserved and ubiquitous. Mutations affecting mRNA and mRNA processing or export factors, which cause aberrant
retention of mRNAs in the nucleus, are thus emerging as contributors to an important class of human genetic disorders. Here, we report
that variants in THOC2, which encodes a subunit of the highly conserved TREX mRNA-export complex, cause syndromic intellectual
disability (ID). Affected individuals presented with variable degrees of ID and commonly observed features included speech delay,
elevated BMI, short stature, seizure disorders, gait disturbance, and tremors. X chromosome exome sequencing revealed four missense
variants in THOC2 in four families, including family MRX12, first ascertained in 1971. We show that two variants lead to decreased
stability of THOC2 and its TREX-complex partners in cells derived from the affected individuals. Protein structural modeling showed
that the altered amino acids are located in the RNA-binding domains of two complex THOC2 structures, potentially representing two
different intermediate RNA-binding states of THOC2 during RNA transport. Our results show that disturbance of the canonicalmolecular
pathway of mRNA export is compatible with life but results in altered neuronal development with other comorbidities.Human neuronal development is an extremely complex
process. It requires proper function and dosage of thou-
sands of genes, as demonstrated by the complexity of
currently knowngenetic architecture of neurodevelopmen-
tal disorders (NDDs) such as intellectual disability (ID), epi-
lepsy, or autism.1 The recent revolution in systematic DNA
sequencing and its application to large cohorts has dramat-
ically accelerated identification of a plethora of potentially
causative NDD variants. In-depth functional investigations
on these variants are essential for timely and meaningful
translation of this knowledge for short (diagnosis) and
long-term (prognosis and treatment) clinical benefit.
Variants in excess of 100 human X chromosome genes
have been identified as causing X-linked NDDs, also
known as X-linked ID, or XLID. Many more such disease-
causing variants remain to be discovered, especially for
non-syndromic forms.2 Here, we implicate THOC2 vari-
ants in XLID. As part of systematic X chromosome exome
re-sequencing of ID-affected individuals from 405 fam-
ilies,3 we identified THOC2 variants in four multigenera-
tional families. These variants are not present in >60,000
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which are unlikely to contain variants from individuals
with NDDs. All four variants lead to missense substitu-
tions, a class of mutations for which it is notoriously
difficult to assign functional effect. The variants in
THOC2 co-segregate with the phenotype in extended ped-
igrees (Figures 1A and 1B and Figure S1), affect highly
conserved amino acids (Figure S2), and are predicted to
be pathogenic by different bioinformatic tools (Table S1).
The variant identified in the large Australian family,
MRX12,4 (c.1313T>C [p.Leu438Pro], [GenBank:
NM_001081550.1]) initiallymapped outside the published
linkage interval. However, upon reanalysis and inclusion
of additional family members, we were able to redefine
the linkage interval between markers DXS8067 and
DXS8009 (chrX: 119,360,400–126,174,300; UCSC
Genome Browser hg19); this region overlaps THOC2
(data not shown). Other THOC2 variants were identified
in the European families D45 (c.937C>T [p.Leu313Phe],
[GenBank: NM_001081550.1]), L22, (previously published
as MRX355; c.2399T>C [p.Ile800Thr], [GenBank:
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Figure 1. THOC2 Missense Variants Identified By X Chromosome Exome Sequencing
(A) Pedigrees of the families affected by THOC2 missense variants. Sanger sequencing confirmed co-segregation of the variants with
the phenotype. The pedigree of family MRX12 has been updated since it was first published.4 Roman numerals on the left of each pedi-
gree indicate individual generation. Abbreviations are as follows: *, has a mutation; WT, does not have a mutation.
(B) Photographs of MRX12, D45, and L22 (previously MRX35) affected family members who harbor THOC2 variants.[GenBank: NM_001081550.1]). The calculated LOD scores
for MRX12, D45, L22, and T134 were 3.6, 1.2, 2.1, and 1.2
(combined LOD ¼ 8.1), respectively. All procedures fol-
lowed were in accordance with the ethical standards of
the Women’s and Children’s Health Network Human
Research Ethics Committee, and proper informed consent
was obtained.
All affected males in this study had ID, but this varied in
severity from borderline to severe. Common additionalThe Amerclinical features of the affected individuals (n¼ 20) include
speech delay, short stature, elevated BMI, and a truncal
obesity pattern in older males in two of the four families
(Table 1 and Table S2). A variety of neurological symptoms,
including tremors, gait disturbance, and seizure disorder,
were observed. Neuroradiological findings detected in the
limited number of individuals who had had CNS imaging
included mild ventriculomegaly, gliosis, inferior cerebellar
vermis dysplasia, and cervical cord compression. Lessican Journal of Human Genetics 97, 302–310, August 6, 2015 303
Table 1. Clinical Features of Individuals with THOC2 Mutations
Family T134
(p.Ser1012Pro) Family MRX12 (p.Leu438Pro) Family L22 (p.Ile800Thr)
Family D45
(p.Leu313Phe)
Summary:
Affected/
Total
(Percentage)II-3 III-1 III-2 III-13 III-17 IV-2 IV-11 IV-12 V-2 V-7 V-8 II-5 III-1 III-2 III-3 III-6 III-7 III-4 III-7 III-8
Gender male male male male male male male male male male male male male male male male male male male male NA
Age (year) 9 5 21 77 61 63 51 51 30 14 9 44 43 42 34 30 28 24 30 38 NA
Perinatal Features
Prematurity    þ þ    þ           þ 4/20 (20%)
Low birth weight   þ    þ  þ  þ          4/20 (20%)
Neurologic Features
Intellectual disability mod bord mod mod mod-sev mod mild mild mild mod mild mild-mod mod-sev mod mod mod mod sev mild-mod mild NA
Speech delay þ  þ þ  þ þ þ þ þ þ þ þ þ þ   þ   14/20 (70%)
Hypotonia þ þ þ þ þ    þ þ þ  þ     þ   10/20 (50%)
Hyperkinesia            þ    þ þ þ   4/20 (20%)
Tremor     þ þ þ þ þ         þ þ þ 8/20 (40%)
Epilepsy þ  þ          þ     þ (GTC) þ  5/20 (25%)
Gait disturbances þ    þ þ       þ     þ b b 5/20 (25%)
Behavior problems þ (ASD)     þ      þ þ  þ þ þ þ (SM) þ (SM)  9/20 (45%)
Anxiety problems     þ þ               2/20 (10%)
Depression      þ  þ             2/20 (10%)
Brain MRI and/or CT ND ND ND ND CCC, glio ND ND ND N ND N ND VM ND ND ND ND VM, CH CVD ND 4/6 (67%)
Growth Parameters
Microcephaly   þ  þ  þ   þ þ          5/20 (25%)
Short stature (%P3)    þ þ þ þ þ þ þ þa þ þ þ þ  þ    13/20 (65%)
Overweight (BMI R 25) ND ND ND  þ þ  þ þ   þ þ þ þ þ   þ  10/17 (59%)
Dysmorphisms
Broad high forehead     þ    þ       þ þ    4/20 (20%)
High palate    þ þ þ þ   þ þ       ND ND ND 6/17 (35%)
Large ears (>2 SDs)    þ þ þ               3/20 (15%)
Small penis and/or
microorchidism
   ND ND ND ND ND ND    þ ND þ þ þ ND  ND 4/11 (36%)
(Continued on next page)
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The Amercommon clinical features included microcephaly and mi-
croorchidism and/or microphallus. We did not recognize
a distinctive facial gestalt (Figure 1B) or overlapping
pattern of congenital anomalies. One of the boys was diag-
nosed with growth-hormone deficiency and is being suc-
cessfully treated with growth-hormone replacement. One
female from family L22 (II-2 in Figure 1A) had border-
line-mild ID; otherwise, carrier females were not noted to
have any NDDs. Taken together, our genetic and clinical
data implicate these THOC2 variants in the causation of
NDDs. This conclusion is also supported by the recent pub-
lication of an individual with cognitive impairment and
who carries a de novo chromosome translocation that
includes PTK2-THOC2 fusion genes.6 A de novo THOC2
missense variant (c.1550A>G [p.Tyr517Cys], [GenBank:
NM_001081550.1]) was recently identified in a female
with moderate-severe ID, speech problems, epileptic en-
cephalopathy, cortical visual impairment, and gait distur-
bances7 (Epi4k Consortium and the Epilepsy Phenome/
Genome Project investigators, personal communication).
Human THOC2 encodes a 1,593-aa, 183-kDa nuclear
protein with 98% amino acid identity to mouse THOC2.
THOC2 forms part of the THO sub-complex (THOC1–3
and THOC5–7), which is an essential component of the
large TREX complex (THO, UAP56, Aly, CIP29, PDIP3,
ZC11A, and Chtop).8,9 THO proteins are related only by
name and do not share significant sequence similarity.
THOC2 is in high abundance in the developing and
mature human10–12 and adult mouse brains.6 We observed
THOC2 in primary mouse hippocampal and cortical neu-
rons and human cerebral cortex and hippocampus
(Figure S3). THOC2 function is critical for many living or-
ganisms as indicated by studies in yeast, roundworms, fruit
flies, and vertebrates.6,13–17 THOC2 depletion has been
shown to (1) interfere with mRNA export, chromosome
alignment, mitotic progression, and genomic stability in
humans13,15 and (2) stimulate neurite outgrowth in pri-
mary rat hippocampal neurons.6 Depletion of other
TREX subunits also interferes with mRNA export, resulting
in nuclear retention of mRNAs.15,16,18 Mouse Thoc2, along
with Thoc5, is required for epithelial stem cell self-renewal
and differentiation.19 Thoc2 depletion in Drosophila
Schneider 2 (S2) cells results in significant mRNA nuclear
retention, inhibition of protein synthesis and cell prolifer-
ation, and chromosome misalignment.16,17 thoc2-
knockout Caenorhabditis elegans are slow growing, sterile,
have functional defects in specific sensory neurons, and
die prematurely from defective progression of meiosis.6,14
Thoc2 is an essential gene for zebrafish embryonic develop-
ment because Thoc2 inactivation causes multiple anatom-
ical abnormalities.20
To investigate the functional effect of THOC2 variants,
we used lymphoblastoid cell lines (LCLs; immortalized B
lymphocytes) from at least one affected individual from
each family. LCLs have been successfully used for inferring
the biological relevance of pathway mutations causing
neurological disease.21,22 We sought to determine theican Journal of Human Genetics 97, 302–310, August 6, 2015 305
Figure 2. Mutations Affect THOC2
Stability, Whereas mRNA Expression Is
Unaltered
(A) THOC2 mRNA expression remained
unaltered in LCLs derived from affected in-
dividuals in comparison to expression in
LCLs from control individuals. Amounts
of THOC2 mRNA were assayed by qRT-
PCR and normalized to the housekeeping
gene GPBP1’s mRNA. Primers are listed in
Table S3. Error bars show SDs, which
were calculated from three independent
experiments.
(B) THOC2 (and THOC1, THOC3, THOC5,
and THOC7) amounts were lower in
p.Leu438Pro and p.Ile800Thr altered cells
(boxed), but not in p.Ser1012Pro or
p.Leu313Phe LCLs, than in control LCLs.
Protein lysates from control and mutant
LCLs were analyzed by western blotting.
b-tubulin probing was used as a loading
control. LCL proteins were extracted and
western blotting was performed as re-
ported previously.23 Western blots were
probed with the following antibodies: rab-
bit anti-THOC2 (303-629A), rabbit anti-
NCBP1/CBP80, rabbit anti-THOC1, rabbit
anti-Aly, rabbit anti-SRAG/Chtop (Bethyl
laboratories), rabbit anti-THOC7, rabbit
anti-THOC3 (Sigma-Aldrich), rabbit anti-
CIP29 (Thermo Scientific), and rabbit
b-tubulin (Abcam).
(C) Amounts of p.Leu438Pro THOC2 were
reduced in fibroblasts from five different
affected individuals from the MRX12 family. Protein lysates from control and mutant fibroblasts were analyzed by western blotting
with the antibodies shown. Probing for b-tubulin was used as a loading control.
(D) Mutations affect THOC2 turnover. For generating Myc-tagged human THOC2 expression plasmids, THOC2 coding sequence was
PCR amplified from brain cDNA with hTHOC2-XbaI-XhoI-F and hTHOC2-NotI-R primers (Table S3) and cloned at XhoI-NotI sites in
the pCMV-Myc mammalian expression vector. Each mutation was introduced by the overlap PCR method using the primers listed in
Table S3. All constructs were validated by Sanger sequencing. Untransfected HEK293T cells or HEK293T cells transfected with wild-
type or altered Myc-tagged THOC2 and EGFP expression plasmid were treated with the translation inhibitor cycloheximide (CHX)
and harvested at different time points after CHX addition. Cell lysates were analyzed by western blotting with an antibody to the
Myc tag, EGFP (transfection control), or b-tubulin (loading control). Whereas amounts of the endogenous, wild-type, or p.Leu313Phe
THOC2 proteins declined slowly over a period of 8.0 hr, p.Leu438Pro (5.4 hr), p.Ile800Thr (1.7 hr), or p.Ser1012Pro (3.3 hr) amounts
declined more rapidly. The amounts of THOC2 and loading-control b-tubulin were measured by quantification of the band intensities
with ImageJ software. THOC2 amounts were relativized to a b-tubulin loading control for determining the half-life of proteins. Each
experiment was repeated three times, and the results of one representative experiment are shown. Data shown are the mean 5 SD.
Note that western blot signals for p.Leu438Pro, p.Ile800Thr, and p.Ser1012Pro at 0 hr look different than those in Figure 2E. This is
because blots were exposed for durations different to those shown in Figure 2E.
(E) THOC2 variants affect stability of ectopic recombinant Myc-tagged THOC2 proteins. Total lysates of HEK293T cells transfected with
wild-type THOC2 (WT), altered Myc-tagged THOC2, or empty vector (EV) and EGFP expression plasmid were analyzed by western blot-
ting with an antibody to the Myc tag, EGFP (transfection control), or b tubulin (loading control).effect of THOC2 variants on protein localization or stabil-
ity. Using immunofluorescence staining assays, we saw
no mislocalization of ectopic Myc-tagged altered THOC2
in HeLa cells and primary mouse cortical neurons (E18;
data not shown). We also observed no impact on THOC2
mRNA expression in mutant LCLs by qRT-PCR (Figure 2A).
However, when compared to that of controls, the amount
of altered THOC2 was significantly reduced in two LCLs
(with the c.1313T>C [p.Leu438Pro] and c.2399T>C
[p.Ile800Thr] variants) but were unchanged in LCLs
harboring the c.3034T>C (p.Ser1012Pro) and c.937C>T
(p.Leu313Phe) variants (Figure 2B). Given that THOC2
depletion destabilizes the THO sub-complex proteins
THOC1, THOC3, THOC5, and THOC7 of the TREX com-306 The American Journal of Human Genetics 97, 302–310, August 6plex in HeLa cells,8 we investigated the amounts of these
complex partners in affected cells. We detected reduced
amounts of these THO subunits in LCL lysates from the
c.1313T>C (p.Leu438Pro) and c.2399T>C (p.Ile800Thr)
mutants, but not in those of the c.3034T>C (p.Ser1012-
Pro) and c.937C>T (p.Leu313Phe) mutants. Protein
amounts of the other TREX subunits, Aly, UAP56, and
Chtop, remained unchanged (Figure 2B). THO sub-com-
plex instability was confirmed with five different primary
skin fibroblasts from the affected individuals of the
MRX12 family with the c.1313T>C (p.Leu438Pro) muta-
tion (Figure 2C). Immunofluorescence showed very low
amounts of diffused THOC2 nuclear staining in
c.1313T>C (p.Leu438Pro) fibroblasts in comparison to, 2015
Figure 3. THOC2 Immunofluorescence Staining Is Significantly
Reduced in THOC2 p.Leu438Pro Fibroblasts
Fibroblasts seeded on coverslips precoated with BD BioCoat were
fixed with 4% paraformaldehyde for 10 min at room temperature
and permeabilized with 0.2% Triton X-100 for 10 min at room
temperature. Cells were then incubated with rabbit anti-THOC2
antibody (303-630A; Bethyl Laboratories) at 500 ng/ml in 10%
horse serum in 1 3 PBS overnight at 4C and then in a 1:2,500
dilution of Alexa Fluor 488 donkey anti-rabbit IgG (HþL) antibody
in 10% horse serum in 1 3 PBS for 1 hr at room temperature and
mounted in ProLong Gold Antifade Mountant with DAPI. Cells
were imaged with an Axiocam camera (AxioCam MRm). Scale
bars represent 20 mm. See also Figure S4.bright speckled staining in controls (Figure 3 and
Figure S4). Reduced THOC2 amounts in LCLs and skin
fibroblasts from the c.1313T>C (p.Leu438Pro)-affected
individuals (MRX12) and in LCLs from the c.2399T>C
(p.Ile800Thr)-affected individuals (L22) strongly suggest
compromised THOC2 function.
Because THOC2 is known to be ubiquitylated,24,25 the
reduced amounts of p.Leu438Pro and p.Ile800Thr proteins
are most likely the result of enhanced proteasome-medi-
ated degradation. To test this, we subsequently compared
the turnover rates of endogenous and ectopic Myc-tagged
wild-type or altered recombinant THOC2 in the presence
of the translational inhibitor cycloheximide. Whereas the
endogenous wild-type and tagged p.Leu313Phe THOC2The Amerproteins have half-lives of about 8.0 hr, both the p.Leu438-
Pro and p.Ile800Thr altered proteins showed significantly
shorter half-lives of 5.4 hr and 1.7 hr, respectively
(Figure 2D). This is consistent with our results obtained
on endogenous altered THOC2 in the cells derived from
the affected individuals (see Figures 2B and 2C). These re-
sults were also consistent with the reduced amounts of
ectopic THOC2 p.Leu438Pro and p.Ile800Thr in untreated
HEK293T cells (Figure 2E). Interestingly however, the
amount of altered p.Ser1012Pro also declined rapidly
(3.3 hr) in the presence of cycloheximide (Figure 2D),
which might be due to the addition of an epitope tag to
the altered THOC2. No change in the amount of EGFP
from the co-transfected plasmid over the course of cyclo-
heximide sampling indicated that the differences in
amount of THOC2 at various time points were not due
to differences in the transfection efficiency of THOC2
expression plasmids (Figures 2D and 2E).
We also investigated the predicted impact of altered
amino acid residues on THOC2 by using a structural model
of THOC2 (SPARKS-X program26,27). We built THOC2
complex models by aligning the predicted model to
known protein-RNA complex structures (Figure S5). Pre-
dicted THOC2 structures showed that the p.Leu313Phe
and p.Leu438Pro variants identified in this study and the
previously reported p.Tyr517Cys variant are located in
the RNA-binding regions. The predicted complex struc-
tures suggest two potential intermediate RNA-binding
states of THOC2 in transporting RNAs (Figure 4).
The process of mRNA export is tightly regulated and
highly conserved from yeast to mammals.30,31 Mutations
that cause mRNA-export problems are rare because of their
substantial impact on cells, organs, and individuals.32,33 For
example, mutations in the human mRNA-export mediator
GLE1 (MIM: 603371) result in a severe fetal motor neuron
disease34 (lethal congenital contracture syndrome 1 [MIM:
253310]) and amyotrophic lateral sclerosis.35 Impaired
RNA transport out of the nucleus can be caused by a
splice-site mutation in COL1A1 (MIM: 120150) in some
affected individuals with osteogenesis imperfect, type I36
(MIM: 166200). Impaired RNA transport out of the nucleus
can also be caused by toxic CUG expansion in the 30 UTR of
the dystrophiamyotonica-protein kinasemRNA in individ-
uals affected by myotonic dystrophy 1 (MIM: 160900).33,37
In addition, a missense mutation (c.136G>A [p.Gly46Arg])
has been described as causing THOC6 (MIM: 615403) loss
of function and protein mislocalization to the cytoplasm
and was associated with a syndromic form of autosomal-
recessive ID.38More recently,mutations inDCPS, encoding
an mRNA decapping enzyme (MIM: 610534), and EDC3,
encoding enhancer of mRNA decapping 3 (MIM: 609842),
have been implicated in ID.39,40
All human cells require mRNA export for efficient pro-
tein synthesis, yet tissue-specific defects due to mutations
in general mRNA-export factors have been observed.33 In
mice, Thoc5 depletion interferes with the maintenance of
hematopoiesis,41,42 and Thoc1 deficiency interferes withican Journal of Human Genetics 97, 302–310, August 6, 2015 307
Figure 4. Models of the Predicted
Complex Structure of the THOC2-RNA
Complex
(A) Complex structure was built on the
basis of the template 1m8y. Variants
p.Leu313Phe and p.Leu438Pro are located
in mRNA-binding sites.
(B) Complex structure was built on the
basis of the template 3a6p. Variant
Tyr517Cys is in an mRNA-binding site.
The workflow used for predicting the
THOC2-RNA interaction is shown (Fig-
ure S4). First, the sequence of THOC2 was
analyzed by SPARKS-X, which predicts
several potential protein structures. Then,
the best structure model was compared to
a library of 1,164 RNA-binding proteins,
and the two best-aligned complex-structure models were generated on the basis of chains 3a6pA and 1m8yA by SPalign28 and had
SP-scores of 0.68 and 0.65, respectively. A score > 0.5 indicates homologous structures, which were selected for building the complex
models. From the complex models, a protein residue and a RNA base were considered in contact if the shortest distance between any
pair of heavy atoms from them was within 4.5A˚. For the first complex structure, variants p.Leu313Phe and p.Leu438Pro were located
in the mRNA-binding domain, but p.Leu313Phe interacted with RNA. The other two variants, p.Ile800Thr and p.Ser1012Pro, were
located on another domain, which was annotated with DNA-binding function by Pfam.29testis development.43 Embryonic lethality of Thoc1- and
Thoc5-knockout mice also suggests a requirement for the
THO complex during early development.30 It appears
that different tissues might require different amounts of
specific export factors for their function.30,33 Given that
THOC2 is highly expressed in the developing and mature
human brain,10–12 it is not surprising that dysregulation
of THOC2 function leads to neurodevelopmental clinical
outcomes.
THOC2, THOC1, and THOC7 depletion results in severe
mRNA-export blockage.8 Complete absence of THOC2 is
most likely lethal. The correspondence between the abun-
dance of THOC2 and the extent of mRNA-export blockage
suggests that THOC2 is an essential mRNA-export factor. 8
In addition, evidence from lower-animal studies predicts
that complete Thoc2 deficiency would cause severe devel-
opmental defects.6,14,16,17,20 This is consistent with the
observation that THOC2 is intolerant to variation (residual
variation intolerance score ¼ 0.53, 18.95th percentile)44
and is a highly constrained human gene.45 We therefore
assume that the clinical manifestations in our affected in-
dividuals are most likely the consequence of a partial
rather than complete loss of THOC2 function. This is
consistent with the reduced amount of THOC2 (and
consequently reduced stability of THOC1, THOC3,
THOC5, and THOC7) rather than complete absence of
THOC2. Whether TREX export activity is altered by
reduced THOC2 amounts alone or by the simultaneous
reduction of other THO subunits is not clear at present.
Notably, however, THOC2 p.Leu438Pro and p.Ile800Thr
instability was associated with short stature (in 13/14 indi-
viduals) in the two families. This might be due to reduced
cell proliferation, as also observed in Thoc2-depleted
Drosophila S2 cells16 resulting from impaired mRNA
export. The mechanism of perturbed p.Leu313Phe and
p.Ser1012Pro THOC2 function is not clear at present,
although these variants might have an effect on THOC2308 The American Journal of Human Genetics 97, 302–310, August 6interaction with RNA or other proteins, which subse-
quently results in altered mRNA export.
In conclusion, our data indicate that partial loss-of-
function THOC2 variants cause NDD with a broad pheno-
typic spectrum. We predict that mRNA export is altered in
cells harboring THOC2 mutations, which most likely
impair protein synthesis, and thus underpins clinical pre-
sentations in the affected individuals. Taken together, our
results identify THOC2 and the nuclearmRNA-export com-
plex as crucial factors for proper neuronal development.
Supplemental Data
Supplemental Data include five figures and three tables and can be
found with this article online at http://dx.doi.org/10.1016/j.ajhg.
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